Serán BioScience, LLC, a drug development partner, has completed two new buildings and began construction of a third facility at its new 100,000 ft2 commercial manufacturing campus in Bend, OR.  The new campus will encompass a 50,000 ft2 manufacturing facility, with an adjacent 50,000 ft2 space dedicated to specialized packaging and supply chain operations. The expansion is part of Serán’s mission to provide integrated support from first-in-human (FiH) trials through commercial-scal...